(-)-gallocatechin gallate has been researched along with 5-(n,n-hexamethylene)amiloride in 1 studies
Studies ((-)-gallocatechin gallate) | Trials ((-)-gallocatechin gallate) | Recent Studies (post-2010) ((-)-gallocatechin gallate) | Studies (5-(n,n-hexamethylene)amiloride) | Trials (5-(n,n-hexamethylene)amiloride) | Recent Studies (post-2010) (5-(n,n-hexamethylene)amiloride) |
---|---|---|---|---|---|
19 | 0 | 10 | 145 | 0 | 34 |
Protein | Taxonomy | (-)-gallocatechin gallate (IC50) | 5-(n,n-hexamethylene)amiloride (IC50) |
---|---|---|---|
Urokinase-type plasminogen activator | Homo sapiens (human) | 2.4 | |
Adenosine receptor A2a | Homo sapiens (human) | 2.685 | |
Adenosine receptor A2b | Homo sapiens (human) | 0.27 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, L; Bassi, ÊJ; Cardoso, SH; da Silva Santos-Júnior, PF; da Silva-Júnior, EF; de Andrade Brandão, J; Silva, LR; Xavier de Araújo-Júnior, J | 1 |
1 review(s) available for (-)-gallocatechin gallate and 5-(n,n-hexamethylene)amiloride
Article | Year |
---|---|
Druggable targets from coronaviruses for designing new antiviral drugs.
Topics: Animals; Antiviral Agents; Drug Design; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2 | 2020 |